UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000015847 |
|---|---|
| Receipt number | R000018406 |
| Scientific Title | A phase II, biomarker study using digital PCR method in EGFR mutated, advanced lung adenocarcinoma patients treated with afatinib. WJOG8114LTR |
| Date of disclosure of the study information | 2014/12/05 |
| Last modified on | 2019/07/17 16:02:11 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2014/12/04 14:44:47 | ||
| 2 | Update | 2014/12/04 14:50:54 | Key secondary outcomes |
|
| 3 | Update | 2015/01/21 10:19:00 | Anticipated trial start date |
|
| 4 | Update | 2015/02/21 12:33:34 | Recruitment status |
|
| 5 | Update | 2015/12/04 09:12:31 | Blinding |
|
| 6 | Update | 2015/12/04 09:13:01 | Recruitment status |
|
| 7 | Update | 2016/06/06 09:12:49 | Name of primary person or sponsor Organization |
|
| 8 | Update | 2016/12/05 09:15:21 | Publication of results |
|
| 9 | Update | 2018/04/03 15:27:29 | Recruitment status |
|
| 10 | Update | 2019/07/17 15:59:56 | Publication of results URL related to results and publications Number of participants that the trial has enrolled |
|
| 11 | Update | 2019/07/17 16:02:11 | Recruitment status Date of IRB Last follow-up date |
